NCT06834386View on ClinicalTrials.gov

Suvorexant for Insomnia to Prevent Delirium in Hospitalized Cancer Patients

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

February 26, 2025

Primary Completion Date

April 24, 2025

Study Completion Date

April 24, 2025

Conditions
Advanced Malignant Solid NeoplasmDeliriumHematopoietic and Lymphatic System NeoplasmInsomnia
Interventions
OTHER

Best Practice

Receive standard of care

OTHER

Electronic Health Record Review

Ancillary studies

OTHER

Interview

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

DRUG

Suvorexant

Given PO

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER